The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand

被引:8
作者
Xiridou, Maria
van Griensven, Frits
Tappero, Jordan W.
Martin, Michael
Gurwith, Marc
Vanichseni, Suphak
Kittikraisak, Wanitchaya
Coutinho, Roel
Choopanya, Kachit
机构
[1] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[2] Municipal Hlth Serv, Amsterdam, Netherlands
[3] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand
[4] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
[5] VaxGen Inc, Brisbane, Qld, Australia
[6] Bangkok Vaccine Evaluat Grp, Bangkok, Thailand
[7] Acad Med Ctr, Amsterdam, Netherlands
关键词
dual infection; HIV-1; subtypes; injecting drug users; mathematic models; superinfection; Thailand; treatment;
D O I
10.1097/QAI.0b013e318093dea5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The HIV epidemic among injecting drug users (IDUs) in Bangkok was initially dominated by HIV subtype B and later by the recombinant CRF01_AE. The present study investigates the distribution of the 2 variants in time and how it is affected by changes in injecting risk behavior and treatment. A mathematic model describing the spread of HIV subtype B and CRF01_AE among IDUs was developed, and data from the AIDSVAX B/E cohort of IDUs in Bangkok were used. From the model, it was calculated that during 1999 to 2003, the annual incidence of HIV was around 0.6 and 2.7 to 3.9 infections per 100 person-years for subtype B and CRF01_AE, respectively. Of the new infections, 18% and 72% are first infections with subtype B and CRF01_AE, respectively, and 9% are super-infections. With increases in risk behavior, the fraction of super-infections rises. If treatment reduces the infectivity of CRF01_AE more than that of subtype B, the fraction of subtype B infections should increase. Subtype B should remain prevalent in a small but considerable fraction of the population for a long time. Changes in risk behavior and the introduction of treatment may alter the distribution of subtypes, but CRT01_AE should remain dominant.
引用
收藏
页码:468 / 475
页数:8
相关论文
共 35 条
  • [1] Blower Sally M., 2005, Current Drug Targets - Infectious Disorders, V5, P179, DOI 10.2174/1568005054201616
  • [2] SENSITIVITY AND UNCERTAINTY ANALYSIS OF COMPLEX-MODELS OF DISEASE TRANSMISSION - AN HIV MODEL, AS AN EXAMPLE
    BLOWER, SM
    DOWLATABADI, H
    [J]. INTERNATIONAL STATISTICAL REVIEW, 1994, 62 (02) : 229 - 243
  • [3] A tale of two futures: HIV and antiretroviral therapy in San Francisco
    Blower, SM
    Gershengorn, HB
    Grant, RM
    [J]. SCIENCE, 2000, 287 (5453) : 650 - 654
  • [4] A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study
    Carr, A
    Chuah, J
    Hudson, J
    French, M
    Hoy, J
    Law, M
    Sayer, D
    Emery, S
    Cooper, DA
    [J]. AIDS, 2000, 14 (09) : 1171 - 1180
  • [5] CHOOPANAYA K, 1992, AIDS, V5, P1509
  • [6] Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
    Detels, R
    Muñoz, A
    McFarlane, G
    Kingsley, LA
    Margolick, JB
    Giorgi, J
    Scharager, LD
    Phair, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17): : 1497 - 1503
  • [7] Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment
    Dorrucci, M
    Balducci, M
    Pezzotti, P
    Sinicco, A
    Alberici, F
    Rezza, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (01): : 65 - 70
  • [8] Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission
    Eron, JJ
    Vernazza, PL
    Johnston, DM
    Seillier-Moiseiwitsch, S
    Alcorn, TM
    Fiscus, SA
    Cohen, MS
    [J]. AIDS, 1998, 12 (15) : F181 - F189
  • [9] Mortality of drug addicts in the United Kingdom 1967-1993
    Ghodse, H
    Oyefeso, A
    Kilpatrick, B
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (03) : 473 - 478
  • [10] Greenhalgh David, 1997, Journal of Biological Systems, V5, P151, DOI 10.1142/S0218339097000126